Medline Financial Results
Medline reported Q3 2026 net sales of $7.9 billion, a 10.4% increase year-over-year, driven by new customer signings and existing customer growth. The company raised its full-year organic sales guidance and announced a new $1 billion share repurchase program authorized by the Board of Directors.
- Term
- Q3 2026
“Medline delivered another strong quarter, with double-digit net sales growth, reflecting continued momentum across our business. Our commercial execution remains strong, including continued progress toward our annual total new customer signings goal.”
Jim Boyle, chief executive officer of Medline